nicardipine and labetalol

nicardipine has been researched along with labetalol in 58 studies

Research

Studies (58)

TimeframeStudies, this research(%)All Research%
pre-19904 (6.90)18.7374
1990's6 (10.34)18.2507
2000's16 (27.59)29.6817
2010's24 (41.38)24.3611
2020's8 (13.79)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Johans, C; Kinnunen, PK; Söderlund, T; Suomalainen, P1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Lombardo, F; Obach, RS; Waters, NJ1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Chen, X; Lin, X; Skolnik, S; Wang, J1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Ram, CV1
Calder, AA; Forbes, CD; Greer, IA; Walker, JJ1
Littler, WA; Smith, SA1
Elghozi, JL; Meyer, P; Saad, MA1
Feldman, RL; Hill, JA; Lambert, CR; Prida, XE1
Bilello, K; Cole, F; Jaffin, J; Malcolm, D; Powell, C; Schultz, S1
Abdelwahab, W; Frishman, W; Landau, A1
Ikenoue, T; Matsuda, Y; Misumi, K; Sakamoto, H1
Groshong, T1
Avramov, MN; Husain, MM; Stool, LA; White, PF1
Marik, PE; Varon, J2
Broad, C; Ferri, E; Kross, RA; Leung, D; Melendez, JA; Pratila, M; Veronesi, M1
Adams, RE; Aiyagari, V; Diringer, MN; Grubb, RL; Powers, WJ; Videen, TO; Yundt, KD; Zazulia, AR1
Abroug, F; Boussarssar, M; Elatrous, S; Marghli, S; Nouira, S; Ouanes Besbes, L; Sakkouhi, M1
Mansour, G; Mansour, J1
Downing, M; Perdue, L; Thornton, L; White, PF; Zhang, Y1
Ziliene, V1
Frishman, WH; Schlocker, SJ; Tejani, N; Veresh, M1
Komotar, RJ; Mayer, SA; Mocco, J; Rose, JC1
Coplin, WM; Janisse, J; Liu-Deryke, X; Norris, G; Parker, D; Rhoney, DH1
Feig, DI; Moffett, BS; Mott, AR; Thomas, CA; Wagner, JL1
Beutler, JJ; de Gooijer, A; Gaillard, CA; Kroon, AA; van den Born, BJ; van den Meiracker, AH1
Baumann, BM; Borczuk, P; Cannon, CM; Chandra, A; Cline, DM; Diercks, D; Hiestand, B; Hsu, A; Jois-Bilowich, P; Kaminski, B; Levy, P; Nowak, RM; Peacock, WF; Schrock, JW; Varon, J1
Hilleman, DE; Levy, PD; Peacock, WF; Rhoney, DH; Varon, J1
Marik, PE; Rivera, R1
Hilleman, DE; Malesker, MA1
Apfel, CC; Do, SH; Hwang, JW; Jeon, YT; Kim, CS; Ro, YJ; Ryu, JH; Whelan, R1
Barletta, JF; DeShane, RS; Figueroa, BE; McAllen, KJ; Woloszyn, AV1
Agarwal, S; Badjatia, N; Carpenter, AM; Claassen, J; Lantigua, H; Lee, K; Lesch, C; Li, M; Mayer, SA; Ortega-Gutierrez, S; Reccius, A; Schmidt, JM; Thomas, J1
Coplin, W; Levy, PD; Liu-DeRyke, X; Parker, D; Rhoney, DH1
Cassiere, HA; Liang, D; Yu, PJ1
de Groot, CJ; Meuleman, T; Nooij, LS; Roelofs, R; Visser, S; Vos, P1
Farias, S; Gonzalez, M; Levy, PD; Peacock, WF1
Baumann, BM; Borczuk, P; Cannon, CM; Chandra, A; Cline, DM; Diercks, DB; Hiestand, B; Hsu, A; Jois-Bilowich, P; Kaminski, B; Levy, P; Nowak, RM; Peacock, WF; Schrock, JW; Soto-Ruiz, KM; Varon, J1
Chandra, A; Freiermuth, CE; Peacock, WF1
Cortes, J; Hall, AB; McKay, C1
Becker, KJ; Starr, JB; Tirschwell, DL1
Hecht, JP; Richards, PG1
Dierkhising, RA; Kuper, PJ; Mara, KC; Poyant, JO; Rabinstein, AA; Ritchie, BM; Wijdicks, EFM1
Abrams, RI; Baxi, PV; Herring, MJ; Korbet, SM; Lichtenstein, SJ1
Desai, A; Hanni, C; Mohamed, W; Parker, D; Saber, H; Sadeghi, M; Singh, A1
Carrera, JF; Chiota-McCollum, NA; Sorace, BJ; Southerland, AM; Worrall, BB1
Binz, S; Joyce, K; Levy, P; McNaughton, C; Miller, J1
El-Ghoroury, H; Hecht, JP; Sudekum, DM1
Brown, CS; Cabrera, D; Farrell, K; Gerberi, DJ; Mattson, AE; Oliveira J E Silva, L; Rabinstein, AA1
Behymer, TP; Bettin, M; Christianson, T; Coleman, ER; Divani, A; Flaherty, ML; Gilkerson, LA; James, ML; King, NKK; Krishnamoorthy, V; Langefeld, CD; McCauley, JL; Ng, Y; Qi, W; Shah, S; Testai, FD; Walsh, KB; Woo, D1
Cho, I; Choe, KR; Jeong, DE; Kim, HJ; Kim, MK; Lee, KN; Park, JY1
Han, J; Oh, AY1
Farley, TM1

Reviews

15 review(s) available for nicardipine and labetalol

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Management of hypertensive emergencies: changing therapeutic options.
    American heart journal, 1991, Volume: 122, Issue:1 Pt 2

    Topics: Emergencies; Humans; Hydralazine; Hypertension; Labetalol; Nicardipine; Nitroprusside

1991
Antihypertensive agents--the race for third place.
    Journal of clinical and hospital pharmacy, 1985, Volume: 10, Issue:2

    Topics: Adrenergic alpha-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Captopril; Diazoxide; Felodipine; Humans; Hydralazine; Indoramin; Labetalol; Minoxidil; Nicardipine; Nifedipine; Vasodilator Agents; Verapamil

1985
Management of hypertensive urgencies and emergencies.
    Journal of clinical pharmacology, 1995, Volume: 35, Issue:8

    Topics: Administration, Oral; Antihypertensive Agents; Emergencies; Enalaprilat; Female; Humans; Hydralazine; Hypertension; Infusions, Parenteral; Labetalol; Nicardipine; Nitroglycerin; Nitroprusside

1995
The diagnosis and management of hypertensive crises.
    Chest, 2000, Volume: 118, Issue:1

    Topics: Antihypertensive Agents; Aortic Aneurysm; Aortic Dissection; Clonidine; Diazoxide; Enalaprilat; Female; Fenoldopam; Humans; Hypertension; Labetalol; Nicardipine; Nifedipine; Nitroprusside; Phentolamine; Pre-Eclampsia; Pregnancy; Propanolamines; Trimethaphan

2000
[Antihypertensive management in acute cerebral stroke].
    Medicina (Kaunas, Lithuania), 2005, Volume: 41, Issue:1

    Topics: Acute Disease; Adult; Antihypertensive Agents; Brain Injuries; Cerebrovascular Circulation; Emergencies; Female; Fenoldopam; Humans; Hypertensive Encephalopathy; Intracranial Aneurysm; Intracranial Pressure; Labetalol; Male; Models, Biological; Nicardipine; Nitroglycerin; Nitroprusside; Stroke; Subarachnoid Hemorrhage; Time Factors; Vasodilator Agents

2005
Pathophysiology and medical management of systemic hypertension in preeclampsia.
    Current hypertension reports, 2006, Volume: 8, Issue:6

    Topics: Adrenergic beta-Antagonists; Aspirin; Calcium; Calcium Channel Blockers; Cerebral Hemorrhage; Female; Glomerular Filtration Rate; Humans; Hypertension; Ischemia; Labetalol; Liver; Nicardipine; Nifedipine; Placenta; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy; Prostaglandins; Stroke

2006
Blood pressure management in patients with intracerebral and subarachnoid hemorrhage.
    Neurosurgery clinics of North America, 2006, Volume: 17 Suppl 1

    Topics: Antihypertensive Agents; Blood Flow Velocity; Blood Pressure; Blood Volume; Brain; Brain Ischemia; Evidence-Based Medicine; Homeostasis; Humans; Intracranial Aneurysm; Intracranial Hemorrhage, Hypertensive; Intracranial Pressure; Labetalol; Nicardipine; Oxygen Consumption; Propanolamines; Subarachnoid Hemorrhage; Vasospasm, Intracranial

2006
Perioperative hypertension management.
    Vascular health and risk management, 2008, Volume: 4, Issue:3

    Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Enalaprilat; Fenoldopam; Hemodynamics; Humans; Hydralazine; Hypertension; Incidence; Labetalol; Nicardipine; Nitroglycerin; Nitroprusside; Perioperative Care; Postoperative Complications; Propanolamines; Pyridines; Surgical Procedures, Operative; Vascular Resistance; Vasodilator Agents

2008
A systematic review of nicardipine vs labetalol for the management of hypertensive crises.
    The American journal of emergency medicine, 2012, Volume: 30, Issue:6

    Topics: Acute Disease; Antihypertensive Agents; Humans; Hypertension; Labetalol; Nicardipine

2012
Hypertensive emergencies: an update.
    Current opinion in critical care, 2011, Volume: 17, Issue:6

    Topics: Acute Disease; Adrenergic beta-Antagonists; Antihypertensive Agents; Blood Pressure; Critical Care; Critical Illness; Emergency Medical Services; Humans; Hypertension; Labetalol; Nicardipine; Prevalence; Propanolamines; United States

2011
The optimal treatment of severe hypertension in pregnancy: update of the role of nicardipine.
    Current pharmaceutical biotechnology, 2014, Volume: 15, Issue:1

    Topics: Antihypertensive Agents; Female; Humans; Hypertension; Hypotension; Infant, Newborn; Labetalol; Nicardipine; Pregnancy

2014
Hypertension Management in Emergency Departments.
    American journal of hypertension, 2020, 10-21, Volume: 33, Issue:10

    Topics: Acute Disease; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Chronic Disease; Drug Therapy, Combination; Emergency Service, Hospital; Humans; Hypertension; Labetalol; Nicardipine; Nitroprusside; Practice Guidelines as Topic; Pyridines; Referral and Consultation; Sodium Chloride Symporter Inhibitors; Undiagnosed Diseases

2020
Comparison of Intravenous Antihypertensives on Blood Pressure Control in Acute Neurovascular Emergencies: A Systematic Review.
    Neurocritical care, 2022, Volume: 37, Issue:2

    Topics: Antihypertensive Agents; Blood Pressure; Emergencies; Humans; Hypertension; Labetalol; Nicardipine; Nitroprusside

2022
Hypertensive Emergency: Parenteral Antihypertensives and Population Data.
    Current hypertension reports, 2023, Volume: 25, Issue:12

    Topics: Antihypertensive Agents; Emergencies; Humans; Hypertension; Hypertensive Encephalopathy; Labetalol; Nicardipine; Randomized Controlled Trials as Topic

2023

Trials

13 trial(s) available for nicardipine and labetalol

ArticleYear
Effects of nicardipine and labetalol on the acute hemodynamic response to electroconvulsive therapy.
    Journal of clinical anesthesia, 1998, Volume: 10, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Anesthetics, Intravenous; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Double-Blind Method; Drug Combinations; Electroconvulsive Therapy; Electroencephalography; Glycopyrrolate; Heart Rate; Humans; Infusions, Intravenous; Injections, Intravenous; Labetalol; Methohexital; Middle Aged; Muscarinic Antagonists; Neuromuscular Depolarizing Agents; Nicardipine; Placebos; Prospective Studies; Seizures; Succinylcholine

1998
A comparative study between a calcium channel blocker (Nicardipine) and a combined alpha-beta-blocker (Labetalol) for the control of emergence hypertension during craniotomy for tumor surgery.
    Anesthesia and analgesia, 2000, Volume: 91, Issue:4

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Analysis of Variance; Anesthesia Recovery Period; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Bradycardia; Brain Neoplasms; Calcium Channel Blockers; Chi-Square Distribution; Craniotomy; Enalaprilat; Female; Humans; Hypertension; Hypotension; Incidence; Labetalol; Male; Middle Aged; Nicardipine; Prospective Studies; Tachycardia; Treatment Outcome

2000
Autoregulation of cerebral blood flow surrounding acute (6 to 22 hours) intracerebral hemorrhage.
    Neurology, 2001, Jul-10, Volume: 57, Issue:1

    Topics: Acute Disease; Adult; Aged; Antihypertensive Agents; Blood Pressure; Cerebral Hemorrhage; Cerebrovascular Circulation; Female; Homeostasis; Humans; Labetalol; Male; Middle Aged; Nicardipine; Tomography, X-Ray Computed

2001
Short-term treatment of severe hypertension of pregnancy: prospective comparison of nicardipine and labetalol.
    Intensive care medicine, 2002, Volume: 28, Issue:9

    Topics: Adult; Antihypertensive Agents; Female; Humans; Hypertension; Labetalol; Nicardipine; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Prospective Studies; Treatment Outcome; Tunisia

2002
The use of nicardipine for electroconvulsive therapy: a dose-ranging study.
    Anesthesia and analgesia, 2005, Volume: 100, Issue:2

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Calcium Channel Blockers; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Electroconvulsive Therapy; Electroencephalography; Female; Hemodynamics; Humans; Hypertension; Labetalol; Male; Middle Aged; Monitoring, Intraoperative; Nicardipine; Seizures

2005
CLUE: a randomized comparative effectiveness trial of IV nicardipine versus labetalol use in the emergency department.
    Critical care (London, England), 2011, Volume: 15, Issue:3

    Topics: Acute Disease; Adult; Aged; Antihypertensive Agents; Blood Pressure; Emergency Service, Hospital; Female; Humans; Hypertension; Labetalol; Male; Middle Aged; Nicardipine; Time Factors; Treatment Outcome

2011
Intravenous labetalol compared with intravenous nicardipine in the management of hypertension in critically ill patients.
    Journal of critical care, 2012, Volume: 27, Issue:5

    Topics: Aged; Antihypertensive Agents; Blood Pressure; Critical Illness; Female; Hospital Charges; Humans; Hypertension; Infusions, Intravenous; Labetalol; Male; Middle Aged; Nicardipine; Retrospective Studies

2012
Comparative prophylactic and therapeutic effects of intravenous labetalol 0.4 mg/kg and nicardipine 20 μg/kg on hypertensive responses to endotracheal intubation in patients undergoing elective surgeries with general anesthesia: a prospective, randomized,
    Clinical therapeutics, 2012, Volume: 34, Issue:3

    Topics: Adult; Anesthesia, General; Antihypertensive Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Elective Surgical Procedures; Female; Humans; Hypertension; Injections, Intravenous; Intubation, Intratracheal; Labetalol; Male; Middle Aged; Nicardipine; Prospective Studies; Time Factors; Treatment Outcome; Young Adult

2012
A prospective evaluation of labetalol versus nicardipine for blood pressure management in patients with acute stroke.
    Neurocritical care, 2013, Volume: 19, Issue:1

    Topics: Aged; Antihypertensive Agents; APACHE; Blood Pressure; Female; Hospital Mortality; Humans; Hypertension; Labetalol; Male; Middle Aged; Nicardipine; Prospective Studies; Stroke; Treatment Outcome

2013
Impact of initial blood pressure on antihypertensive response in patients with acute hypertension.
    The American journal of emergency medicine, 2014, Volume: 32, Issue:8

    Topics: Acute Disease; Antihypertensive Agents; Blood Pressure; Creatinine; Emergency Service, Hospital; Humans; Hypertension; Infusions, Intravenous; Labetalol; Male; Middle Aged; Nicardipine; Time Factors; Treatment Outcome

2014
The management of acute hypertension in patients with renal dysfunction: labetalol or nicardipine?
    Postgraduate medicine, 2014, Volume: 126, Issue:4

    Topics: Acute Disease; Antihypertensive Agents; Comorbidity; Double-Blind Method; Female; Humans; Hypertension; Labetalol; Male; Middle Aged; Nicardipine; Prospective Studies; Renal Insufficiency

2014
Characteristics of patients that do not initially respond to intravenous antihypertensives in the emergency department: subanalysis of the CLUE trial.
    The western journal of emergency medicine, 2015, Volume: 16, Issue:2

    Topics: Antihypertensive Agents; Emergency Service, Hospital; Emergency Treatment; Female; Humans; Hypertension; Infusions, Intravenous; Labetalol; Male; Middle Aged; Nicardipine; Prospective Studies; Treatment Failure

2015
Initial antihypertensive agent effects on acute blood pressure after intracerebral haemorrhage.
    Stroke and vascular neurology, 2022, Volume: 7, Issue:5

    Topics: Antihypertensive Agents; Blood Pressure; Cerebral Hemorrhage; Humans; Hydralazine; Hypertension; Labetalol; Nicardipine

2022

Other Studies

30 other study(ies) available for nicardipine and labetalol

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability.
    Journal of medicinal chemistry, 2004, Mar-25, Volume: 47, Issue:7

    Topics: Blood-Brain Barrier; Lipid Bilayers; Micelles; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship; Surface Properties

2004
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
    Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:2

    Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity

2011
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
Aspirin with an adrenergic or a calcium-channel-blocking agent as new combination therapy for arterial thrombosis.
    Lancet (London, England), 1985, Feb-09, Volume: 1, Issue:8424

    Topics: Aspirin; Drug Synergism; Ethanolamines; Humans; Labetalol; Nicardipine; Nifedipine; Platelet Aggregation; Thrombosis

1985
Baroreflex sensitivity alteration following transient hemispheric ischaemia in rats: protective effect of alphamethyldopa and guanfacine.
    Clinical and experimental pharmacology & physiology, 1986, Volume: 13, Issue:7

    Topics: Animals; Blood Pressure; Enalapril; Guanfacine; Guanidines; Heart Rate; Ischemic Attack, Transient; Labetalol; Male; Methyldopa; Nicardipine; Phenylacetates; Pressoreceptors; Rats; Rats, Inbred Strains; Reflex; Tachycardia

1986
Systemic and coronary hemodynamics of labetalol in normotensive patients with ischemic heart disease.
    Cardiovascular drugs and therapy, 1988, Volume: 2, Issue:3

    Topics: Coronary Circulation; Coronary Disease; Diltiazem; Hemodynamics; Humans; Labetalol; Nicardipine

1988
Diaspirin crosslinked hemoglobin (DCLHb): control of pressor effect with anti-hypertensive agents.
    Artificial cells, blood substitutes, and immobilization biotechnology, 1994, Volume: 22, Issue:3

    Topics: Animals; Antihypertensive Agents; Aspirin; Blood Pressure; Blood Substitutes; Hemoglobins; Hypertension; Labetalol; Nicardipine; Nitroglycerin; Prazosin; Rats

1994
Effects of antihypertensive drugs on maternal and fetal hemodynamics and uterine blood flow in pregnant goats--comparison of nicardipine and labetalol.
    The Journal of veterinary medical science, 1996, Volume: 58, Issue:6

    Topics: Animals; Antihypertensive Agents; Blood Pressure; Carbon Dioxide; Female; Fetal Blood; Fetus; Goats; Heart Rate; Heart Rate, Fetal; Hemodynamics; Hydrogen-Ion Concentration; Labetalol; Maternal-Fetal Exchange; Nicardipine; Oxygen; Partial Pressure; Pregnancy; Pregnancy, Animal; Regional Blood Flow; Time Factors; Uterus

1996
Hypertensive crisis in children.
    Pediatric annals, 1996, Volume: 25, Issue:7

    Topics: Antihypertensive Agents; Emergencies; Enalapril; Humans; Hypertension; Isradipine; Labetalol; Nicardipine; Nitroprusside

1996
Nicardipine or labetalol as short-term treatment for severe hypertension of pregnancy.
    Current hypertension reports, 2004, Volume: 6, Issue:6

    Topics: Antihypertensive Agents; Female; Humans; Hypertension, Pregnancy-Induced; Labetalol; Nicardipine; Pregnancy; Randomized Controlled Trials as Topic; Severity of Illness Index

2004
A comparison of nicardipine and labetalol for acute hypertension management following stroke.
    Neurocritical care, 2008, Volume: 9, Issue:2

    Topics: Acute Disease; Aged; Antihypertensive Agents; APACHE; Blood Pressure; Brain Ischemia; Cerebral Hemorrhage; Female; Humans; Hypertension; Labetalol; Male; Middle Aged; Nicardipine; Retrospective Studies; Stroke; Treatment Outcome

2008
Safety and efficacy of intravenous labetalol for hypertensive crisis in infants and small children.
    Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2011, Volume: 12, Issue:1

    Topics: Analysis of Variance; Antihypertensive Agents; Chi-Square Distribution; Female; Humans; Hypertension; Infant; Infusions, Intravenous; Labetalol; Linear Models; Male; Nicardipine; Nitroprusside; Retrospective Studies; Treatment Outcome

2011
Dutch guideline for the management of hypertensive crisis -- 2010 revision.
    The Netherlands journal of medicine, 2011, Volume: 69, Issue:5

    Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Captopril; Emergency Treatment; Humans; Hypertension; Hypertensive Retinopathy; Internal Medicine; Labetalol; Netherlands; Nicardipine; Nifedipine; Nitroprusside; Practice Guidelines as Topic

2011
Retrospective evaluation of nicardipine versus labetalol for blood pressure control in aneurysmal subarachnoid hemorrhage.
    Neurocritical care, 2012, Volume: 16, Issue:3

    Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Critical Care; Female; Humans; Hypertension; Labetalol; Male; Middle Aged; Nicardipine; Retrospective Studies; Stroke; Subarachnoid Hemorrhage; Treatment Outcome

2012
Effectiveness and safety of nicardipine and labetalol infusion for blood pressure management in patients with intracerebral and subarachnoid hemorrhage.
    Neurocritical care, 2013, Volume: 18, Issue:1

    Topics: Adult; Aged; Antihypertensive Agents; Cerebral Hemorrhage; Cohort Studies; Drug Therapy, Combination; Early Medical Intervention; Female; Humans; Hypertension; Infusions, Intravenous; Labetalol; Male; Middle Aged; Nicardipine; Retrospective Studies; Subarachnoid Hemorrhage; Treatment Outcome

2013
Acute intramural hematoma of the aorta complicated by spinal cord ischemia.
    Journal of cardiac surgery, 2013, Volume: 28, Issue:6

    Topics: Acute Disease; Administration, Oral; Adult; Antihypertensive Agents; Aortic Diseases; Blood Pressure; Drainage; Female; Heart Function Tests; Hematoma; Humans; Infusions, Intravenous; Intracranial Pressure; Labetalol; Magnetic Resonance Imaging; Nicardipine; Spinal Cord Ischemia; Tomography, X-Ray Computed; Treatment Outcome

2013
Time to Blood Pressure Control Before Thrombolytic Therapy in Patients With Acute Ischemic Stroke: Comparison of Labetalol, Nicardipine, and Hydralazine.
    The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses, 2015, Volume: 47, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Brain Ischemia; Female; Fibrinolytic Agents; Humans; Hydralazine; Hypertension; Infusions, Intravenous; Labetalol; Male; Middle Aged; Nicardipine; Retrospective Studies; Stroke; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator

2015
Labetalol Use Is Associated With Increased In-Hospital Infection Compared With Nicardipine Use in Intracerebral Hemorrhage.
    Stroke, 2017, Volume: 48, Issue:10

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Cerebral Hemorrhage; Cross Infection; Female; Humans; Hypertension; Labetalol; Male; Middle Aged; Nicardipine; Prospective Studies; Retrospective Studies

2017
Continuous-Infusion Labetalol vs Nicardipine for Hypertension Management in Stroke Patients.
    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2018, Volume: 27, Issue:2

    Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Drug Administration Schedule; Female; Humans; Hypertension; Infusions, Intravenous; Labetalol; Male; Middle Aged; Nicardipine; Patient Admission; Retrospective Studies; Stroke; Time Factors; Treatment Outcome; Vasodilator Agents

2018
Nicardipine Reduces Blood Pressure Variability After Spontaneous Intracerebral Hemorrhage.
    Neurocritical care, 2019, Volume: 30, Issue:1

    Topics: Administration, Intravenous; Adult; Aged; Antihypertensive Agents; Blood Pressure; Cerebral Hemorrhage; Female; Humans; Hydralazine; Labetalol; Male; Middle Aged; Nicardipine; Retrospective Studies; Treatment Outcome

2019
Without Warning: Scleroderma Renal Crisis.
    The American journal of medicine, 2019, Volume: 132, Issue:2

    Topics: Acute Kidney Injury; Amlodipine; Antihypertensive Agents; Humans; Hypertension; Labetalol; Lisinopril; Male; Nicardipine; Scleroderma, Limited

2019
Nicardipine Associated Risk of Short-Term Mortality in Critically Ill Patients with Ischemic Stroke.
    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2019, Volume: 28, Issue:5

    Topics: Aged; Antihypertensive Agents; Blood Pressure; Brain Ischemia; Critical Illness; Databases, Factual; Female; Hospital Mortality; Humans; Hypertension; Hypotension; Labetalol; Male; Middle Aged; Nicardipine; Retrospective Studies; Risk Assessment; Risk Factors; Stroke; Time Factors; Treatment Outcome

2019
Delay to Tissue Plasminogen Activator in Hypertensive Stroke Patients: An Analysis of Delay Duration Across Agents.
    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2020, Volume: 29, Issue:2

    Topics: Aged; Antihypertensive Agents; Blood Pressure; Drug Administration Schedule; Female; Fibrinolytic Agents; Humans; Hydralazine; Hypertension; Infusions, Intravenous; Labetalol; Male; Nicardipine; Retrospective Studies; Stroke; Thrombolytic Therapy; Time Factors; Time-to-Treatment; Tissue Plasminogen Activator; Treatment Outcome

2020
Blood Pressure Control in Acute Stroke: Labetalol or Nicardipine?
    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2021, Volume: 30, Issue:9

    Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Bradycardia; Calcium Channel Blockers; Female; Heart Rate; Humans; Hypertension; Hypotension; Infusions, Intravenous; Labetalol; Male; Middle Aged; Nicardipine; Retrospective Studies; Stroke; Time Factors; Treatment Outcome; United States

2021
Use of continuous infusion of nicardipine to control persistent postpartum hypertension: A retrospective study.
    Medicine, 2022, Dec-23, Volume: 101, Issue:51

    Topics: Antihypertensive Agents; Blood Pressure; Female; Humans; Hydralazine; Hypertension; Labetalol; Nicardipine; Postpartum Period; Pregnancy; Retrospective Studies

2022
Precipitation of sugammadex with nicardipine and labetalol: A laboratory research.
    Fundamental & clinical pharmacology, 2023, Volume: 37, Issue:5

    Topics: Labetalol; Neuromuscular Blockade; Neuromuscular Nondepolarizing Agents; Nicardipine; Research; Sugammadex

2023